Abiopharma

🔍 Israeli Natan (Executive)

Company: KALTURA INC (KLTR)

Report Date: 2026-08-05

Detailed Transactions and Holdings:

• Sold 196,432 shares of Common Stock at $1.8227 per share (Direct)
  Date: 2026-08-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,872,427.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 62,890 shares of Common Stock at $2.0098 per share (Direct)
  Date: 2026-08-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,809,537.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.52 to $1.94 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.